These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32179240)

  • 21. From Mucuna Pruriens to deep brain stimulation: A two-decade case history.
    Margolesky J; Shpiner DS; Moore H; Singer C; Jagid J; Luca CC
    Parkinsonism Relat Disord; 2020 Aug; 77():26-27. PubMed ID: 32604054
    [No Abstract]   [Full Text] [Related]  

  • 22.
    Rai SN; Chaturvedi VK; Singh P; Singh BK; Singh MP
    3 Biotech; 2020 Dec; 10(12):522. PubMed ID: 33194526
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters.
    Manyam BV; Dhanasekaran M; Hare TA
    Phytother Res; 2004 Feb; 18(2):97-101. PubMed ID: 15022157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poisoning After Ingestion of Mucuna pruriens Seeds on Reunion Island.
    Maillot A; Schmitt C; Marteau A
    Wilderness Environ Med; 2022 Mar; 33(1):122-124. PubMed ID: 34895813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
    J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Levodopa for Parkinson's disease: What have we learned?].
    Juri C C; Chaná C P
    Rev Med Chil; 2006 Jul; 134(7):893-901. PubMed ID: 17130974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial. HP-200 in Parkinson's Disease Study Group.
    J Altern Complement Med; 1995; 1(3):249-55. PubMed ID: 9395621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
    Cilia R; Cereda E; Akpalu A; Sarfo FS; Cham M; Laryea R; Obese V; Oppon K; Del Sorbo F; Bonvegna S; Zecchinelli AL; Pezzoli G
    Brain; 2020 Aug; 143(8):2490-2501. PubMed ID: 32844196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative NMR analysis of L-Dopa in seeds from two varieties of Mucuna pruriens.
    Fernandez-Pastor I; Luque-Muñoz A; Rivas F; Medina-O'Donnell M; Martinez A; Gonzalez-Maldonado R; Haidour A; Parra A
    Phytochem Anal; 2019 Jan; 30(1):89-94. PubMed ID: 30216583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucuna pruriens (L.) DC. seed extract inhibits lipopolysaccharide-induced inflammatory responses in BV2 microglial cells.
    Rachsee A; Chiranthanut N; Kunnaja P; Sireeratawong S; Khonsung P; Chansakaow S; Panthong A
    J Ethnopharmacol; 2021 Mar; 267():113518. PubMed ID: 33122120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyphenol oxidase (PPO) arm of catecholamine pathway catalyzes the conversion of
    Saranya G; Sruthi D; Jayakumar KS; Jiby MV; Nair RA; Pillai PP; Jayabaskaran C
    Plant Physiol Biochem; 2021 Sep; 166():1032-1043. PubMed ID: 34274890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Availability of Therapies and Services for Parkinson's Disease in Africa: A Continent-Wide Survey.
    Hamid E; Ayele BA; Massi DG; Ben Sassi S; Tibar H; Djonga EE; El-Sadig SM; Amer El Khedoud W; Razafimahefa J; Kouame-Assouan AE; Ben-Adji D; Lengané YTM; Musubire AK; Mohamed MH; Phiri TE; Nestor N; Alwahchi WA; Neshuku SN; Ocampo C; Sakadi F; Maidal MA; Ngwende GW; Hooker J; Okeng'o K; Charway-Felli A; Atadzhanov M; Carr J; Okubadejo NU; Shalash A
    Mov Disord; 2021 Oct; 36(10):2393-2407. PubMed ID: 34080713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of Levodopa in the Unani Drug Mucuna pruriens Bak. and Its Marketed Formulation by High-Performance Thin-Layer Chromatographic Technique.
    Mohapatra S; Ganguly P; Singh R; Katiyar CK
    J AOAC Int; 2020 Jun; 103(3):678-683. PubMed ID: 31540588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme (ACE) inhibitory potential of standardized Mucuna pruriens seed extract.
    Chaudhary SK; De A; Bhadra S; Mukherjee PK
    Pharm Biol; 2015; 53(11):1614-20. PubMed ID: 25868619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of pharmacological therapy in Parkinson's disease: when, why, and how.
    de Bie RMA; Clarke CE; Espay AJ; Fox SH; Lang AE
    Lancet Neurol; 2020 May; 19(5):452-461. PubMed ID: 32171387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benefits of the combination of mucuna, green tea and levodopa/benserazide in Parkinson's disease].
    Gonzalez-Maldonado R; Gonzalez-Redondo R; Di Caudo C
    Rev Neurol; 2016 Jun; 62(11):524-6. PubMed ID: 27222087
    [No Abstract]   [Full Text] [Related]  

  • 37. Case of levodopa toxicity from ingestion of Mucuna gigantea.
    Tse GG; Kim BB; McMurtray AM; Nakamoto BK
    Hawaii J Med Public Health; 2013 May; 72(5):157-60. PubMed ID: 23795319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiparkinson drug--Mucuna pruriens shows antioxidant and metal chelating activity.
    Dhanasekaran M; Tharakan B; Manyam BV
    Phytother Res; 2008 Jan; 22(1):6-11. PubMed ID: 18064727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic substitution in Parkinson's disease.
    Müller T
    Expert Opin Pharmacother; 2002 Oct; 3(10):1393-403. PubMed ID: 12387685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative genetic analysis of trichome-less and normal pod genotypes of Mucuna pruriens (Fabaceae).
    Dhawan SS; Rai GK; Darokar MP; Lal RK; Misra HO; Khanuja SP
    Genet Mol Res; 2011 Sep; 10(3):2049-56. PubMed ID: 21968621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.